Interstitial Lung Disease Trial, Recruiting NCT06087692 Sponsor: Istanbul University Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06087692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with interstitial lung disease (a condition that causes scarring or inflammation in the lungs) by a lung specialist, are between 40 and 65 years old, and have been receiving ongoing care for this condition for at least 6 months following standard international guidelines.
  • People whose condition is currently stable, meaning no recent flare-ups or infections.
  • People who are able to walk and do not have significant problems with their vision or hearing.
  • People who have the mental ability to understand and follow instructions during the study.

Who may not be able to join:

  • People who have bone, joint, or nerve-related problems that could make exercise difficult or unsafe.
  • People whose medications or medical treatment change during the course of the study.
  • People who have an unstable heart condition.
  • People who are unable or unwilling to cooperate with the study requirements.
  • People who have a diagnosed problem with their vision, hearing, inner ear (balance system), or nervous system that could affect their balance.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aysel Yıldız Özer, Prof., Marmara University

Phone: 5542320882

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul University
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
1 March 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

6 minute walk test; Incremental Shuttle Walk Test; Endurance Shuttle Walk Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov